BE902475A - BIOLOGICALLY ACTIVE TRIDECAPEPTIDES. - Google Patents

BIOLOGICALLY ACTIVE TRIDECAPEPTIDES.

Info

Publication number
BE902475A
BE902475A BE0/215051A BE215051A BE902475A BE 902475 A BE902475 A BE 902475A BE 0/215051 A BE0/215051 A BE 0/215051A BE 215051 A BE215051 A BE 215051A BE 902475 A BE902475 A BE 902475A
Authority
BE
Belgium
Prior art keywords
pro
alkoxycarbonyl
alkyl
aralkoxycarbonyl
aralkyl
Prior art date
Application number
BE0/215051A
Other languages
French (fr)
Inventor
G Perseo
M Gigli
R De Castiglione
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of BE902475A publication Critical patent/BE902475A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Des peptides répondant à la formule Glp-X-Lys-Pro-Tyr-Trp-Pro-Pro-Pro-Y-Tyr-Pro-W-C où X = L-alpha-amino-acide neutre ou acide; A = H ou groupe acyle, alcoxycarbonyle, aralcoxycarbonyle, alkyle ou aralkyle protecteur du groupe amino; B = H ou groupe acyle, alkyle, aralkyle, alcoxycarbonyle ou aralcoxycarbonyle protecteur du groupe hydroxy phénolique; Y et W = L -alpha-amino-acide neutre; C = OH, amino ou Or, NHR, NHR, NR2 ou NH-NH-R' ; R = alkyle en C1- C11, phényle ou aralkyle en C7-C14 et R' = H, R, acyle aliphatique en C1-C11, alcoxycarbonyle en C3-C11 ou aralcoxycarbonyle.Les peptides synthétisées sont utiles dans des procédés de traitement thérapeutique chez l'homme ou l'animal et notamment une stimulation de la sécrétion de la prolactine prituitaire, elles exercent des effets sédatifs inhibant le transit intestinal, et sont antipyrétiques.Peptides corresponding to the formula Glp-X-Lys-Pro-Tyr-Trp-Pro-Pro-Pro-Y-Tyr-Pro-W-C where X = L-alpha-amino acid neutral or acid; A = H or acyl, alkoxycarbonyl, aralkoxycarbonyl, alkyl or aralkyl group protecting the amino group; B = H or acyl, alkyl, aralkyl, alkoxycarbonyl or aralkoxycarbonyl group protecting the phenolic hydroxy group; Y and W = L -alpha-amino acid neutral; C = OH, amino or Gold, NHR, NHR, NR2 or NH-NH-R '; R = C1-C11 alkyl, phenyl or C7-C14 aralkyl and R '= H, R, C1-C11 aliphatic acyl, C3-C11 alkoxycarbonyl or aralkoxycarbonyl. The synthesized peptides are useful in therapeutic treatment processes in humans or animals, and in particular stimulation of the secretion of prolactin proliferative, they exert sedative effects inhibiting intestinal transit, and are antipyretic.

BE0/215051A 1984-05-24 1985-05-22 BIOLOGICALLY ACTIVE TRIDECAPEPTIDES. BE902475A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848413272A GB8413272D0 (en) 1984-05-24 1984-05-24 Biologically active tridecapeptides

Publications (1)

Publication Number Publication Date
BE902475A true BE902475A (en) 1985-09-16

Family

ID=10561441

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215051A BE902475A (en) 1984-05-24 1985-05-22 BIOLOGICALLY ACTIVE TRIDECAPEPTIDES.

Country Status (4)

Country Link
JP (1) JPS6197A (en)
BE (1) BE902475A (en)
DE (1) DE3518086A1 (en)
GB (2) GB8413272D0 (en)

Also Published As

Publication number Publication date
JPS6197A (en) 1986-01-06
DE3518086A1 (en) 1985-11-28
GB8512761D0 (en) 1985-06-26
GB8413272D0 (en) 1984-06-27
GB2156822A (en) 1985-10-16

Similar Documents

Publication Publication Date Title
Johnson et al. Regulation of lymphokine (gamma-interferon) production by corticotropin.
ATE63813T1 (en) PHARMACEUTICAL COMPOSITIONS OF DIHYDROCODEINES/IBUPROFEN AND PROCESSES.
Brunda et al. Inhibition of experimentally‐induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases
IT1190403B (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE TO TREAT THE HUMAN BODY WITH IT
PT76502B (en) Process for the preparation of n-glycosylated carboxamide derivatives with s stimulating effect of the body's inherent defences and their application for the preparation of pharmaceutical compositions having a stimulating effect of body's inherent defences
DE3650358D1 (en) Pharmaceutical compositions containing diphosphonates for the treatment of arthrosis.
ATE123381T1 (en) ADMINISTRATION OF ACTIVE INGREDIENTS TO AQUATIC ANIMALS USING SUPERSONIC.
ATE87485T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PEPTIDES OF THE CHOLECYSTOKININ CERULEIN GROUP FOR THE TREATMENT OF RESPIRATORY AND CARDIAC DISEASES.
PT78275B (en) PROCESS FOR THE PREPARATION OF NOVEL 4-FLAVIUM-CARBOXYLIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
BE902475A (en) BIOLOGICALLY ACTIVE TRIDECAPEPTIDES.
FR2612916B1 (en) TREATMENT OF BOURBIER WATER RELEASE CONTAINING LIGNOSULFONATES
ATE40793T1 (en) PHARMACEUTICAL PREPARATION FOR THERAPEUTIC TREATMENT OF RHEUMATIC DISEASES.
FR2529081B1 (en) THERAPEUTIC COMPOSITION BASED ON 5-HYDROXYDECANOIC ACID OR A DERIVATIVE THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
FR2556593B1 (en) NUTRITIONAL COMPOSITION CONTAINING ALPHA-CETOISOCAPROIC ACID, LEUCIN AND ESSENTIAL AND NON-ESSENTIAL AMINO ACIDS
DE3861494D1 (en) PHARMACEUTICAL COMPOSITION FOR TUMOR TREATMENT.
FR2601030B1 (en) ACID COMPOSITIONS WITH HIGH CONCENTRATIONS OF ACTIVE MATERIALS FOR THE TREATMENT OF WATER AND / OR THE CLEANING OF THE FACILITIES CONTAINING THEM
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
FR2412313A1 (en) PHARMACEUTICAL COMPOSITION BASED ON MONO-SACCHARIDE AND AMINO-ACID FOR ORAL ADMINISTRATIVE USE TO HUMANS
Cohen et al. Enhancement of adrenocorticotrophic activity
JPS646214A (en) Remedy for ulcerative colonopathy
FR2649864B1 (en) PROCESS FOR THE TREATMENT OF FOIE GRAS OR OTHER ANIMAL FLESH PARTS INTENDED FOR CONSUMPTION
JPS53104714A (en) Compound proteins having serum calcium decreasing, immunity promoting actions and their preparation
RO94153A2 (en) CURATIVE MEDICINE FOR TREATMENT OF LIVER PLANTS IN ALL ANIMAL SPECIES
KR890007737A (en) Anti-caking agents
BE905706A (en) HERBICIDE MIXTURES AND THEIR USE FOR THE TREATMENT OF CROPS.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FARMITALIA CARLO ERBA S.P.A.

Effective date: 19900531